Public Health and Gay and Bisexual Men: A Primer for Practitioners, Clinicians, and Researchers

2021 ◽  
pp. e1-e3
Author(s):  
George Ayala ◽  
Andrew Spieldenner

Whatever else it may be, AIDS is a story, or multiple stories, and read to a surprising extent from a text that does not exist: the body of the male homosexual.1 (Am J Public Health. Published online ahead of print June 10, 2021: e1–e3. https://doi.org/10.2105/AJPH.2021.306348 )


Sexual Health ◽  
2019 ◽  
Vol 16 (5) ◽  
pp. 433 ◽  
Author(s):  
Eric P. F. Chow ◽  
Kate Maddaford ◽  
Sabrina Trumpour ◽  
Christopher K. Fairley

The gonorrhoea rate among gay and bisexual men who have sex with men (MSM) has been increasing rapidly in many Western countries. Furthermore, gonorrhoea is becoming increasingly resistant to antibiotics and only limited options remain for treatment. Recent evidence suggests that the oropharynx may play an important role in gonorrhoea transmission. It is hypothesised that reducing the prevalence of oropharyngeal gonorrhoea will also reduce the population incidence of gonorrhoea. Mouthwash has been proposed as a novel non-antibiotic intervention to prevent oropharyngeal gonorrhoea; hence, reducing the probability of antibiotic resistance developing. However, its efficacy is yet to be confirmed by a randomised controlled trial – the findings of which will be available in 2019. If the trial shows mouthwash is effective in preventing gonorrhoea, this finding could potentially be translated into a public health campaign to increase the mouthwash use in the MSM population. This article summarises the current evidence of the effectiveness of mouthwash against gonorrhoea and discusses the potential literature gaps before implementing the mouthwash intervention at a population level.


2014 ◽  
Vol 25 (5) ◽  
pp. 554-568 ◽  
Author(s):  
Daniel E. Siconolfi ◽  
Perry N. Halkitis ◽  
Robert W. Moeller

2021 ◽  
pp. e1-e3
Author(s):  
David W. Purcell

Forty years after the Centers for Disease Control and Prevention’s (CDC’s) June 1981 Morbidity and Mortality Weekly Report about five gay men with a syndrome that came to be called AIDS, both the impact of HIV and the legal landscape in the United States for the most affected population have changed dramatically. Laws, policies, and how they are enforced reflect the values and prejudices of society, and laws can help or hinder public health efforts, regardless of intent. From the outset, HIV aroused widespread fear and new stigmatizing laws and policies, and the crisis revealed injustices in existing laws that compounded stigma and health disparities among the most affected groups. In the 1980s, HIV engulfed already stigmatized communities of gay and bisexual men and other men who have sex with men (MSM) and people who inject drugs. The CDC’s HIV surveillance reports show that, throughout the epidemic, MSM have constituted the majority of annual and prevalent cases, and the burden on racial or ethnic minority MSM has increased disproportionately since the early 1990s.1 It is timely to reflect on the intertwining of HIV, laws, stigma, and inequity in the United States and their intersection with the lives of gay and bisexual men (both cisgender and transgender). (Am J Public Health. Published online ahead of print June 10, 2021: e1–e3. https://doi.org/10.2105/AJPH.2021.306335 )


2017 ◽  
Vol 4 (suppl_1) ◽  
pp. S418-S418 ◽  
Author(s):  
Ian Holloway ◽  
Elizabeth Wu ◽  
Jennifer Gildner ◽  
Vincent Fenimore ◽  
Paula Frew

Abstract Background Men who have sex with men (MSM) are at high risk for invasive meningococcal disease (IMD). Following a 2016 IMD outbreak in Southern California, public health officials issued an advisory that urged at-risk adult gay and bisexual men, and all people with HIV, to obtain immunizations. Despite public health efforts to increase MCV4 coverage, uptake and acceptance among MSM remains unknown. Thus, our study sought to: (1) estimate reported MCV4 immunization among MSM in Los Angeles, CA; and (2) document the facilitators and barriers to the newest vaccination recommendation following the recent outbreak. Methods From November 2016 through February 2017, we used venue-based sampling to recruit MSM in Los Angeles (N = 513). Eligible participants completed a 30-minute iPad survey that included items on MCV4 status, sexual behavior, vaccination knowledge and behaviors among other factors. Chi-square and independent sample t-tests were used to determine bivariate associations. Statistically significant variables from bivariate analyses were included in a multivariate logistic regression model predicting MCV4 uptake. Results Participants were young (M=33, SD=10) and racially/ethnically diverse: White (35.7%), Black/African American (14.6%), Hispanic (36.5%), Asian/Pacific Islander (4.1%), Other (9.2%). Reported MCV4 immunization among MSM (25.4%) and MSM living with HIV (37.7%) was low. Statistically significant correlates of MCV4 uptake in our multivariate model included: younger age (aOR=2.51), prior STI diagnosis (aOR=2.21), believing MCV4 vaccination was important (aOR=3.45), having confidence in the MCV4 vaccine (aOR=5.43), and knowing someone who had received the vaccination (aOR=5.79). Conclusion MSM’s perceived health risk, vaccine confidence, and knowledge of someone who received the MCV4 vaccine were important indicators of meningitis immunization in this outbreak context. Provider and public health education efforts may be enhanced by messages that emphasize personal health risks, the safety and efficacy of MCV4, and the importance of meningococcal vaccines for men’s health. Popular opinion leader programs facilitated by someone who had been vaccinated are warranted to enhance MCV4 uptake. Disclosures All authors: No reported disclosures.


Sign in / Sign up

Export Citation Format

Share Document